Overview (04 Nov 2026)
Krebs Biochemicals & Industries Ltd
KREBSBIO
INE268B01013
Pharmaceuticals
Result was last declared on 21 May 2026
1.18
Prev. Close
Previous Close
55.92
Current Close
57.1
Current High
57.5
Current Low
54.5
52 Week High
76.72
52 Week Low
38.52
Resistance 1
58.24
Resistance 2
59.37
Support 1
55.24
Support 2
52.24
Std Deviation
4.57%
DMA 200
58.00
DMA 50
57.43
DMA 20
57.78
Fundamentals and Ratios
Standalone
Trailing EPS
0
Forwad EPS
-6.32
Trailing P/E
NA
Forward P/E
NA
PEG Ratio
1.72
Mkt. Cap (Cr)
Market Cap (Cr)
123.11
Total Debt(Cr)
Tot. Debt(Cr)
226.99
Reserve (Cr)
-192.20
Book Value
NA
P/BV Ratio
NA
ROCE(%)
-10.00
ROE
N/A

 

Financial Result
Standalone
TypeSep-26Jun-26Mar-26Dec-25Sep-25FY25-26
Revenue5.796.986.817.274.1723.73
Other Income0.040.162.000.000.012.03
Total Income5.837.148.817.284.1725.76
Interest1.901.881.911.791.737.09
Expenditure-11.23-9.62-11.15-10.41-10.32-42.69
PBDT0.000.000.000.000.000.00
Depreciation-1.61-1.59-1.57-1.64-1.62-6.42
PBT-5.40-2.48-2.34-3.13-6.14-16.93
Tax0.000.000.000.000.000.00
Equity21.5621.5621.560.000.0021.56
OPM-92.62-34.73-26.56-42.99-147.42-65.74
Net Profit-5.4-2.48-2.34-3.13-6.14-16.93
NPM-92.62-34.73-26.56-42.99-147.42-65.74
EPS-2.5-1.15-1.09-1.45-2.850
Consolidated
TypeFY25-26
Revenue23.7316
Other Income2.03
Total Income25.76
Interest7.09
Expenditure-42.69
PBDT0.00
Depreciation-6.42
PBT-16.93
Tax0.00
Equity21.56
OPM-65.74
Net Profit-16.93
NPM-65.74
EPS0
Annual Reports

Corporate Action
Quarterly Result
Dividend
Bonus
Split

Mutual Fund Holddings